logo

For the Inventor, By the Inventor

Slough, United Kingdom

Lonza Biologics Plc


USPTO Granted Patents = 26

% Expired Patents = 42.3



Forward Citations = 63

Loading Chart...
Loading Chart...

67 inventors (with patents filed for the assignee):

goldMedal Robert Young (7 out of 8 patents)

silverMedal James Rance (4 out of 4 patents)

bronzeMedal Mohsan Waseem Khan (3 out of 8 patents)

4.  Marc Feary (3 out of 4 patents)

5.  Jesus Zurdo (3 out of 8 patents)

6.  Michael J Agostino (2 out of 11 patents)

7.  Lin Zhang (2 out of 3 patents)

8.  Baohong Zhang (2 out of 2 patents)

9.  Christopher M Smales (2 out of 2 patents)

10.  Tom Payne (2 out of 4 patents)

11.  Mark R Whickman (2 out of 2 patents)

12.  Sam Mansoor (2 out of 2 patents)

13.  Johan Desmet (2 out of 9 patents)

14.  Ignace Lasters (2 out of 16 patents)

15.  Andreas Arnell (2 out of 2 patents)


Core Competencies:
Sensor Shield
Mammalian Expression System
Site-Specific Integration
Recombinant Proteins
Expression Vectors
Bioreactor
Cell Culture Medium
Polypeptide Purification
Immunoglobulins
Amino Acid Sequences
Protein Aggregation
Antibody Purification

26 patents:

1. 12760253 - Sterile disconnect for bioprocess systems and method for using same (2026-10-13),
2. 12092483 - Sensor shield (2024-09-17),
3. 11767537 - Mammalian expression system (2023-09-26),
4. 11326185 - Site-specific integration (2022-05-10),
5. 10669541 - Means and methods for the generation of mammalian producer cells for the production of recombinant proteins (2020-06-02),
6. 10294491 - Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences (2019-05-21),
7. 10280436 - Site-specific integration (2019-05-07),
8. 10221209 - Method and system for polypeptide purification (2019-03-05),
9. 10179898 - Bioreactor for the cultivation of mammalian cells (2019-01-15),
10. 10139418 - Rapid method for targeted cell (line) selection (2018-11-27),
11. 9783771 - Three bioreactor system for the cultivation of mammalian cells (2017-10-10),
12. 9783770 - Deepwell plate system with lid (2017-10-10),
13. 9777290 - Expression vectors comprising chimeric cytomegalovirus promoter and enhancer sequences (2017-10-03),
14. 9670446 - Bioreactor for the cultivation of mammalian cells (2017-06-06),
15. 9290563 - Variant immunoglobulins with improved manufacturability (2016-03-22),
Company Overview
Lonza Biologics Plc, based in Slough, GB, specializes in the development and manufacturing of biologics for the pharmaceutical and biotechnology sectors. The company focuses on providing comprehensive solutions for the production of monoclonal antibodies, recombinant proteins, and cell and gene therapies. With a commitment to innovation, Lonza leverages advanced technologies to support clients in bringing life-saving therapies to market, enhancing the efficiency and effectiveness of biopharmaceutical manufacturing processes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Lonza Biologics Plc USPTO Patent Assignee Logo
26 Patents

#9 in Slough

#680 in United Kingdom

#24,826 in the World

Slough, GB
Slough, United Kingdom

Lonza Biologics Plc

Forward Citations = 63

67 inventors:

goldMedal Robert Young (7 out of 8 patents)

silverMedal James Rance (4 out of 4 patents)

bronzeMedal Mohsan Waseem Khan (3 out of 8 patents)

4.  Marc Feary (3 out of 4 patents)

5.  Jesus Zurdo (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lonza Biologics Plc. Retrieved from https://idiyas.com/company/lonza-biologics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…